GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procter & Gamble Health Ltd (BOM:500126) » Definitions » EV-to-FCF

Procter & Gamble Health (BOM:500126) EV-to-FCF : (As of Mar. 14, 2025)


View and export this data going back to 1992. Start your Free Trial

What is Procter & Gamble Health EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Procter & Gamble Health's Enterprise Value is ₹84,137 Mil. Procter & Gamble Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil. Therefore, Procter & Gamble Health's EV-to-FCF for today is .

The historical rank and industry rank for Procter & Gamble Health's EV-to-FCF or its related term are showing as below:

BOM:500126' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 63.84
Current: 41.11

During the past 13 years, the highest EV-to-FCF of Procter & Gamble Health was 63.84. The lowest was 0.00. And the median was 0.00.

BOM:500126's EV-to-FCF is ranked worse than
70.05% of 551 companies
in the Drug Manufacturers industry
Industry Median: 23.05 vs BOM:500126: 41.11

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-14), Procter & Gamble Health's stock price is ₹5239.75. Procter & Gamble Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹142.360. Therefore, Procter & Gamble Health's PE Ratio (TTM) for today is 36.81.


Procter & Gamble Health EV-to-FCF Historical Data

The historical data trend for Procter & Gamble Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procter & Gamble Health EV-to-FCF Chart

Procter & Gamble Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Jun21 Jun22 Jun23 Jun24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -24.67 45.35 50.41 42.84 39.47

Procter & Gamble Health Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 39.47 - -

Competitive Comparison of Procter & Gamble Health's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Procter & Gamble Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Procter & Gamble Health's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procter & Gamble Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Procter & Gamble Health's EV-to-FCF falls into.



Procter & Gamble Health EV-to-FCF Calculation

Procter & Gamble Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=84136.812/0
=

Procter & Gamble Health's current Enterprise Value is ₹84,137 Mil.
Procter & Gamble Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Procter & Gamble Health  (BOM:500126) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Procter & Gamble Health's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5239.75/142.360
=36.81

Procter & Gamble Health's share price for today is ₹5239.75.
Procter & Gamble Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹142.360.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Procter & Gamble Health EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Procter & Gamble Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Procter & Gamble Health Business Description

Traded in Other Exchanges
Address
Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.

Procter & Gamble Health Headlines

No Headlines